Cystic Fibrosis
Click image to view animation.
You must have the newest version of Adobe Flash® and JavaScript enabled.
Cystic fibrosis (CF) is a severe, genetically-determined disease involving the lungs, the gastrointestinal tract, and other organs. With cystic fibrosis, the body produces abnormally thick, sticky mucus (sputum). This mucus clogs the lungs, causing lifethreatening lung infections, and obstructs the pancreas, impairing the ability of the intestines to break down food.
Cystic fibrosis occurs in about 1 in 2,000 live births among white children and at a far lower rate in black and Asian children. Boys and girls get cystic fibrosis equally. At present, only 50% of those diagnosed with CF as infants or young children live beyond their late twenties. However, that percentage is rising as an increasing number of patients are only mildly affected and survive into adult life.
The Cystic Fibrosis Center at NewYork-Presbyterian/Columbia is fully accredited by the Cystic Fibrosis Foundation and provides care annually for over 175 individuals with CF, nearly 40% of whom are adults. Our multidisciplinary team consists of adult and pediatric pulmonary physicians, gastroenterologists, genetic counselors, nutritionists, physical therapists, a nurse clinician, and a social worker.
We work closely with the NewYork-Presbyterian Center for Lung Disease and Transplantation at Columbia University Medical Center, providing ready access for transplant evaluation. Post-transplantation, we continue to work closely with the transplant specialists, to ensure coordinated care.
To contact the Cystic Fibrosis Center at NewYork-Presbyterian/Columbia, please call 212.305.5122.
Diagnosis
Children with cystic fibrosis typically experience repeated pulmonary infections. Since cystic fibrosis affects the glands that secrete sweat, they may also suffer from salt depletion while sweating during hot weather.
Fever, cough, difficulty in breathing, fast respiration, flaring of the nostrils, poor appetite, and reduced activity are typical features of acute cystic fibrosis. Cystic fibrosis is diagnosed with a sweat test, which measures the amount of salt in perspiration. If that test is positive, it should be confirmed with a second test. Since a child's siblings run an increased risk of also having cystic fibrosis, they should be tested as well.
Read about Cystic Fibrosis treatments.
Research
Physicians in the Columbia Presbyterian Cystic Fibrosis Treatment Center regularly participate in clinical research trials studying new treatments for the management of cystic fibrosis. Milestone studies include the Pulmozyme trial, the Thairapy Vest trial, and the TOBI trial. For more information about cystic fibrosis research at the Center, click here.
Related Links
NewYork-Presbyterian/Columbia has taken a leadership role in perfecting techniques and patient selection criteria for lung transplantation in patients with cystic fibrosis. As a result we are home to the largest CF lung transplant program in the New York metropolitan area. Although current management strategies reasonably control the disease into adulthood in pediatric patients, lung transplantation offers e extended survival in patients with advancing disease who have also severe and irreversible airflow obstruction. We have also expanded the program to include patients under the age of 18 years. Transplanted patients with cystic fibrosis may now undergo subsequent transplantation if their grafts fail.
You are trying to load Blausen Medical's Human Atlas.
Either you do not have the newest version of Adobe Flash®, or you have JavaScript disabled.
To use Blausen's Atlas software, you must ensure you have these capabilities.
